VLA 0.00% $1.75 viralytics limited

Ann: Ceasing to be a substantial holder from MS, page-45

  1. 1,172 Posts.
    lightbulb Created with Sketch. 71
    OK... so Cavatak is valuable to Merck and BMS.
    What are the chances a separate agreement exists between both those parties whereby Merck makes the formal offer, BMS agrees not to engage in a bidding war, they share equally in the offer price .... and both gain access to Cavatak?
 
watchlist Created with Sketch. Add VLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.